Daily meet celebrity with new activity
p53 in cell cycle regulation | p53 and cancer | p53 tumor suppressor.
NEOPLASIA 4: p53 gene: The Guardian of the genome. functions, regulation and inactivation
p53 Tumour Suppressor and MDM2
The Role of p53 in Cancer
Is TP53-mutated high-risk MDS the same disease as TP53-mutated AML?
Challenges in treating patients with TP53-mutated AML and future outlooks
ERIC recommendations on TP53 mutation classification
The P53 Gene
Evo-Ed: Breast Cancer and the TP53 Gene
Current knowledge of the TP53 mutation and its role in CLL
Should patients with TP53-mutated MDS receive stem cell transplant?
Testing for IgHV and TP53 mutations to guide treatment decisions in CLL
Removing the Most Common P53 Mutation in Colorectal Cancer Halts Disease Progression
The importance of targeting TP53 in AML and agents being explored
The impact of TP53 mutation on treatment approaches in MCL
p53 Tumour Suppressor (2016) by Etsuko Uno wehi.tv
The impact of p53 mutation on survival in EGFR-mutated NSCLC patients
Is there hope for treating TP53-mutated MDS?
Discovering the p53 cancer protein - Cancer Research UK
Progress in the treatment of TP53 mutated AML
The challenges of treating TP53-mutated AML and MDS
Identifying low-burden TP53 mutations with NGS in CLL
Outcomes of alloHSCT in TP53-mutated AML and MDS
The benefit of allogeneic transplantation in patients with TP53-mutated AML
Dr. Eskelund on Outcomes of TP53-Mutated MCL
Unmet needs in AML: TP53 mutations and maintenance therapy
Treatment recommendations for patients with CLL with del(17p) and TP53 aberrations
An analysis of TP53 mutation in AML and HR-MDS
TP53 Genetic Test
Aziz Nazha, MD: How Do TP53 Mutation Characteristics Affect MDS Outcomes?
The prognostic impact of TP53 mutation in MPNs
TP53 mutations in CLL: a large retrospective analysis
Treatment approaches for patients with TP53-mutated MCL
Dr. Landen Discusses p53 Mutations in Ovarian Cancer
Challenges in treating patients with TP53-mutated MCL & promising novel therapies being explored
Immunological impact of TP53 in MDS
The importance of TP53 in CLL
Updates in the treatment landscape of p53-mutated AML/MDS
TP53 and Deletion 17p as Prognostic Factors in CLL
APR-246 in TP53 mutated MDS and AML
TP53 Testing Should Be Expanded | Ambry Genetics
The importance of TP53 testing in CLL
p53 mutations in cancer
CDKN2A and TP53 mutation in HPV-negative HNSCC
Dr. Pemmaraju on the Challenges of Targeting TP53 Mutations in MDS/AML
Eprenetapopt plus venetoclax and azacitidine in the treatment of TP53-mutated AML
Osimertinib and chemotherapy in EGFR+ lung cancer with TP53 and RB1 alterations
Mutant p53 and oncogenic KRAS drive metastasis in pancreatic cancer
p53 Tumor suppressor and its functions - Role of p53 in various regulatory pathways explained
The role of TP53 in CLL